Ferreira, Tomas http://orcid.org/0000-0003-1465-522X
Polavarapu, Kiran http://orcid.org/0000-0002-8879-6001
Olimpio, Catarina http://orcid.org/0000-0002-0112-5767
Paramonov, Ida http://orcid.org/0000-0001-8666-6054
Lochmüller, Hanns http://orcid.org/0000-0003-2324-8001
Horvath, Rita http://orcid.org/0000-0002-9841-170X
Funding for this research was provided by:
Medical Research Council (MR/V009346/1, MR/S005021/1)
Wellcome Trust (109915/Z/15/Z)
Addenbrooke's Charitable Trust, Cambridge University Hospitals (G100142)
Lily Foundation (Research Grant 2019)
Action for A-T (Research Grant 2022)
Muscular Dystrophy UK (PhD fellowship)
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
Wolfson Foundation
Royal College of Physicians
CIHR (FDN-167281)
Transnational Team Grant (ERT-174211)
Canada Foundation for Innovation (OR2-189333 (NMD4C))
Canada Research Chairs (950-232279)
Canada Research Coordinating Committee (NFRFG-2022-00033)
Government of Canada Canada First Research Excellence Fund
Canadian Institute for Health Research (MFE-491707)
Evelyn Trust (G117372)
Article History
Received: 13 February 2024
Revised: 8 March 2024
Accepted: 8 March 2024
First Online: 28 March 2024
Declarations
:
: The authors have no financial or non-financial interest that are directly or indirectly related to the work submitted for publication.